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Abstract
The mechanisms that regulate the expression of genes encoding extracellular matrix proteins in fibroblasts and other
mesenchymal cells have remained elusive. Studies from several laboratories have indicated that Tax, a trans-regulatory
protein from the human T cell leukemia virus type I not
only augments viral gene expression but also triggers the
expression of various cellular genes. Here, we examined the
hypothesis that the expression of collagen genes may also
be modulated by Tax. NIH-3T3 cells were simultaneously
transfected with a Tax expressor plasmid and a chimeric
construct containing regulatory sequences (-804 to +42 bp)
of the al(I) procollagen gene (COLlAl) promoter. The
results indicated that the promoter activity of the -804 to
+42 bp COLlAl fragment increased up to 12-fold in cells
expressing Tax. Deletion analysis revealed that the region
of COLlAl encompassing nucleotides -174 to -84 contained the Tax-responsive elements. A gene segment encompassing nucleotides -187 to -67, which contained this region, proved sufficient to confer Tax inducibility (2.5-fold)
to a herpes simplex virus thymidine kinase promoter. Stably
transfected NIH-3T3 cell clones that constitutively produce
Tax displayed elevated levels of al (I) procollagen and fibronectin transcripts and increased production and accelerated processing of type I procollagen. These findings suggest
that retroviral proteins may be involved in the pathogenesis
of idiopathic diseases accompanied by collagen overproduction. (J. Clin. Invest. 1995. 96:2413-2420.) Key words: procollagen genes * tax protein * retroviruses * collagen gene
expression * tissue fibrosis

Introduction
Systemic sclerosis and idiopathic pulmonary fibrosis are prototypes of a group of diseases characterized by the excessive
accumulation of collagen and other connective tissue macromolecules in various tissues. The mechanisms responsible for the
exaggerated fibrosis of affected organs in these diseases have
remained elusive despite intensive investigations, although most
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studies indicate abnormalities in the regulation of expression of
the genes encoding extracellular matrix proteins (1, 2).
The intimate mechanisms involved in the regulation of collagen gene expression under normal and pathologic conditions
remain poorly understood (for review see reference 3). The
possibility that viral transformation or expression of viral proteins in connective tissue cells may modulate the regulatory
processes involved in the production of extracellular matrix
proteins by these cells has been examined extensively. Early
studies demonstrated that transformation of fibroblasts and
chondrocytes with the Rous sarcoma virus resulted in marked
inhibition of collagen production and in a change in the differentiated cellular phenotype regarding the collagen types produced
(4-8). We previously described that transformation of embryonic chick vertebral chondrocytes by a temperature-sensitive
mutant of Rous sarcoma virus caused a marked inhibition of
type I collagen production and a concomitant increase in the
production of fibronectin at the permissive temperature (8).
Other studies that examined the effects of viral transformation
on fibroblasts and other mesenchymal cells have indicated that,
with few exceptions, viral transformation results in marked inhibition of collagen gene expression (9).
The HIV-1 Tat protein is a potent transactivator of viral
(10), as well as of a number of endogenous genes including
those encoding cytokines and growth factors (11, 12). We recently demonstrated that transfection of glioblastoma cells with
the gene encoding the HIV-1 Tat protein resulted in increased
expression of the genes encoding types I and III collagens and
fibronectin (13). The purpose of the studies reported here was
to examine the effects of expression of the human T cell leukemia virus type-I (HTLV-1 )' Tax protein, a more potent retroviral transactivator protein than Tat, on the expression of the
al (I) procollagen gene (COLlAl) in NIH-3T3 cells. Our results showed that production of Tax protein in NIH-3T3 cells
caused increased expression of COLlAl and that these effects
occurred at the level of transcription. We also demonstrated that
the cis-acting elements within the a l (I) procollagen promoter
involved in Tax transactivation are contained within a region
of the promoter encompassing nucleotides -174 to -84 with
respect to the transcription initiation site. Furthermore, a gene
segment, encompassing nucleotides -174 to -67, which contained this region of the promoter, was able to confer Tax responsiveness when cloned upstream of a heterologous promoter
linked to a chloramphenicol acetyltransferase (CAT) reporter
gene.

Methods
Cells and plasmids. NIH-3T3 cells were used in all the experiments.
The cells were grown in DME supplemented with 10% calf serum, 1%
1. Abbreviations used in this paper: CAT, chloramphenicol acetyltransferase; HSV, herpes simplex virus; HTLV-1, human T-cell leukemia
virus type I; LTR, long terminal repeat; tk, thymidine kinase.
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Figure 1. Schematic diagram of COLlAl promoter-HSV tk-CAT constructs. The constructs were prepared as described in Methods. (A)
pAC182 contains COLlAl nucleotides -187 to -67 (Tax-responsive
region) cloned immediately upstream of the heterologous HSV tk promoter and the CAT reporter gene. (B) pAC330 contains COLlAl nucleotides -367 to -177 (Tax-unresponsive region) cloned immediately
upstream of the HSV tk promoter and the CAT reporter gene.
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vitamins, 1% glutamine, 1% penicillin-streptomycin, and 0.4% fungizone. The plasmids used were: long terminal repeat (LTR)-Tax, a
recombinant containing the HTLV- 1 Tax gene under the control of the
LTR of HTLV-1 (14); pU3R-CAT, composed of the U3 and R regions
of the HTLV-1 LTR cloned upstream of the CAT gene (15); pNeo, a
plasmid which contains the neomycin resistance gene cloned downstream of the bovine papilloma virus promoter (16); and the constructs
pAC171, pAC198, pAC199, pAC200, pAC204, and pAC205 which are
progressive 5' deletions of the human a 1 (I) procollagen gene promoter
each cloned upstream of the CAT reporter gene. All the pAC constructs
end at nucleotide +42 to assure transcription in a proper reading frame
and their 5' ends are at -804, -675, -463, -369, -174, and-84 bp,
respectively. These recombinant constructs have been described in detail
previously (17). The construct pAC182, was generated by PCR amplification of the region of the human a 1(I) procollagen gene promoter
encompassing nucleotides -187 to -67. This region was cloned into
pCR3II (Invitrogen, San Diego, CA), and XbaI fragments were cloned
immediately upstream of the herpes simplex virus (HSV) thymidine
kinase (tk) promoter of pBLCAT2 (18). The construct pAC330 was
generated by PCR amplification of the upstream COLlAl promoter
region encompassing nucleotides -367 to -177 followed by similar
cloning steps as those used to obtain pAC182. The plasmids pAC182 and
pAC330 were sequenced to confirm their sequence and their orientation
relative to the tk promoter. A schematic diagram of these two constructs
is shown in Fig. 1.
Transfections and CAT assays. For transient transfections, NIH-3T3
cells were plated at a density of 3 x 105 cells per 60-mm culture
dish and 24 h later were transfected by the calcium phosphate/DNA
coprecipitation method (19). In transient transfection assays, 2.5 jg of
each pAC plasmid were cotransfected with 2.5-10 jg of LTR-Tax
plasmid. As a control pU3R-CAT (0.25-0.5 jig) transfections in the
absence or presence of LTR-tax were performed. 48 h after transfections,
extracts were prepared using repeated freezing-thawing of the cells and
CAT assays were performed on the extracts as described (20). For
stable transfections, either 10 jg of LTR-Tax plasmid plus 1 jig of
pNeo plasmid or 1 jg of pNeo plasmid alone were used. The total
2414
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Figure 2. Transactivation of the COLlAl promoter by transient transfection of NIH-3T3 cells with the LTR-Tax expressor plasmid. (A)
Transient transfection of NIH-3T3 cells with 2.5 jg of plasmid pAC171
(-804- +42 of COLlAl cloned upstream of the CAT gene) and increasing amounts of LTR-Tax plasmid (Tax). The chimeric plasmid
pU3R-CAT containing the HTLV-l gene regulatory region pU3R driving CAT was used as a control. (B) Densitometric analysis of the
acetylated forms of chloramphenicol. The bars represent arbitrary densitometric units (ADU). E pAC171; pU3R-CAT.
n,

amount of DNA to be transfected was maintained constant at 15 ,jg per
60-mm culture dish or 20 jig per 100-mm culture dish by addition of
salmon sperm DNA. The selection and maintenance of the neomycinresistant (Neo +) clones was made by supplementing the media with 400
jig/ml Geneticin (G418 sulfate; Boehringer-Mannheim Biochemicals,
Indianapolis, IN), as described previously (21).
RNA isolation and analysis. Total RNA from stable clones cultured
in T175 flasks (Falcon, Becton Dickinson Labware, Lincoln Park, NJ)
was extracted with guanidinium thiocyanate followed by ultracentrifugation in a CsCl gradient (22). 10 jig of total RNA was electrophoresed
in 1.2% agarose-formaldehyde gels, and after electrophoresis the gels
were transferred to nitrocellulose membranes. The membranes were
sequentially hybridized to 32P-labeled cDNAs for murine aI (I) procollagen, fibronectin, and glutaraldehyde 3-phosphate dehydrogenase
(GAPDH). These cDNAs have been described previously (23-25).
Protein analysis. Approximately 5 x 104 cells were seeded in triplicate in 24-well plates with 1 ml of medium containing 400 jig/ml of
G418 and were kept at 370C in a 5% CO2 moist atmosphere. When the
cultures reached confluency, the media were supplemented with 50 jg/
ml of fresh ascorbic acid, and 24 h later, fresh media containing 100
jg/ml of /-aminopropionitrile and 1.5 jiCi/ml of [14C]proline was
added and the incubation continued for 24 h. At the end of the incubation
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period, the media and the cells were separately harvested and protease
inhibitors were added to yield final concentrations of 5 mM EDTA, 0.2
mM PMSF, 5 mM N-ethylmaleimide, and 1 mM p-aminobenzamidine
hydrochloride. Cell layers were disrupted in 300 /1 of 4 M guanidinium
thiocyanate solution and brought to 1 ml with distilled water. Aliquots
of media and cell suspensions were dialyzed overnight against running
water to remove the unincorporated isotope. Total incorporation of
['4C I proline was measured in a scintillation spectrometer and total collagenous proteins were determined by a collagenase digestion assay
(26). The labeled proteins in media and cell layer suspensions were
analyzed by SDS-PAGE under reducing conditions, and the gels were
processed by fluorography and subsequent densitometry.

Results
Transactivation of COLJAI promoter by HTLV-i Tax. To investigate the effect of Tax on the expression of the COLlAl gene,
NIH-3T3 cells were transfected simultaneously with the LTRTax plasmid, a Tax expressor plasmid, and the pAC171 plasmid
containing -804 to +42 bp of the COLlAl promoter cloned
upstream of the CAT reporter gene. The pU3R-CAT plasmid
in which the CAT gene is driven by the HTLV- l promoter was
cotransfected along with the LTR-Tax plasmid as a positive
control. 48 h after transfection the crude protein extracts were

assayed for CAT activity. The results presented in Fig. 2 demonstrate that the CAT activity driven by the -804 to +42 bp
a l (I) procollagen promoter (pAC171 ) progressively increased
in response to increasing concentrations of the LTR-Tax plasmid. The dose-dependent promoter activation induced by Tax
reached a maximal level of 12-fold when 7.5 jig of LTR-Tax
construct was used. Cotransfection with higher concentrations
of the Tax plasmid resulted in a decrease in CAT activity driven
by the a l (I) procollagen gene promoter (data not shown). The

Figure 3. Effects of transient transfections of the LTR-Tax expressor plasmid on the CAT activity driven by
deletion constructs of the COLlA1
promoter. (A) Autoradiogram of CAT
assays performed with extracts from
NIH-3T3 cells that had been cotransfected with 2.5 Ag each of one of various deletion constructs of COLlAl
with 5' endpoints at -804, -675,
-463, -369, -174, and -84 bp and
increasing concentrations (0, 5.0, 7.5
tig) of the LTR-Tax plasmid (Tax).
(B) Densitometric scanning of the autoradiograms. The bars indicate arbitrary densitometric units (ADU) for
the experiment in which 7.5 /ig of
LTR-Tax were used. The regulatory
sequences present in the COLlAl
promoter (-804 to +42 bp) and a
representation of the various deletion
derivatives of the COLlA1 promoter
used are also shown. *P < 0.001.

results of cotransfections of pU3R-CAT, the positive control
plasmid used along with the LTR-Tax plasmid, showed a maximal increase in activity of 17-fold when 5 4g of LTR-Tax
plasmid was used. Cotransfection with higher concentrations
of LTR-Tax resulted in lower expression of the pU3R-CAT
construct. The basal CAT activity driven by this promoter was
similar to that observed in cells transfected with pAC17 1 alone.
These results indicate that expression of Tax protein in the
NIH-3T3 cells by transfection of the Tax expressor plasmid, as
documented in parallel experiments by transactivation of pU3RCAT, caused a dose-dependent stimulation of the expression of
the COLlAl gene.
Identification of COLIAI promoter regions involved in Tax
transactivation. To determine the regions of the COLlAl promoter that are important for the response to Tax transactivation,
deletion mutants of the promoter with various 5' endpoints
(from -804 to -84 bp) cloned upstream of the CAT reporter
gene were cotransfected into NIH-3T3 cells along with the LTRTax plasmid. The results from seven separate experiments (Fig.
3) revealed no statistically significant differences between the
CAT activities driven by constructs with 5 ' end points at -804,
-675, -463, -369, or -174 bp. However, further deletion of
the promoter from -174 to -84 bp resulted in a marked decrease in CAT activity (55% compared to the CAT activity
driven by the -174 bp construct). These results were statistically significant (P < 0.001) and indicate that the most important sequences of the COLlAl promoter involved in Tax
transactivation are located within the region encompassing nucleotides -174 to -84. However, it should be noted that the
-84-bp construct showed some response to Tax, suggesting
that additional cis-elements or a primary response element may
be present in this region of the COLlAl promoter. Examination
of the relevant COLlAl promoter sequences (Fig. 3 B) sugTax Stimulation of Collagen Gene Expression
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linked to an HSV tk promoter. (A) Autoradiogram
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gested that the decrease in CAT activity was likely due to
removal of the promoter regions containing the consensus SPl,
AP-1, and/or the proximal, but not the upstream, CTF-NF1
sequences or to removal of other not previously identified regulatory elements. To confirm that sequences within the COLlAl
promoter region from -174 to -84 bp were necessary and
sufficient for Tax-inducible CAT expression, a fragment of the
COLlAl promoter (-187 to -67 bp) encompassing the Taxresponsive region was subcloned upstream of the HSV tk promoter-CAT transcription unit and was cotransfected into NIH3T3 cells along with the LTR-Tax plasmid. The results (Fig.
4), demonstrated an increase in CAT activity driven by the
construct containing the COLlAl promoter fragment encompassing the Tax-responsive region (pAC182) with increasing
concentrations of transfected Tax and minimal Tax-transactivation of the tk promoter. The promoter activation induced by
LTR-Tax cotransfection reached a maximum of 2.5-fold. In
contrast, there was no increase in CAT activity when the construct pAC330 (containing a Tax-unresponsive region of the
promoter) was cotransfected with LTR-Tax. The results of cotransfections of pU3R-CAT and LTR-Tax plasmid showed a
maximal increase in activity of 15-fold. The basal CAT activity
of the pAC 182 was similar to that observed in cells transfected
with the COLlAl promoter construct pAC204 (5' endpoint at
-174 bp) (data not shown).
Transactivation ofHTLV-I and COLIA] promoters in Taxproducing stable cell lines. To examine further the role of Tax
protein on collagen gene expression, Tax-producing NIH-3T3
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stable clones were established by cotransfection of the LTRTax and the neomycin-resistance plasmid, pNeo. Several stable
clones were obtained after neomycin selection. Expression of
functional Tax in the selected clones was examined by transient
expression of the HTLV-1 LTR. Of 46 clones established, 20
were positive for Tax (Tax+) as illustrated for selected clones
in Fig. 5. The morphology of representative clones of cells
stably transfected with either LTR-Tax plus pNeo or pNeo alone
is shown in Fig. 6. The control clones obtained by transfection

11

Figure 5. Transactivation of the HTLV- 1 promoter in stable clones from
NIH-3T3 cells transfected with the pNeo plasmid alone or with the
LTR-Tax expressor plasmid plus the pNeo plasmid. (Lanes 1-9) Stable
clones from cells transfected with 10 pg of LTR-Tax plasmid plus 1
Mg of pNeo plasmid, transiently transfected with the pU3R-CAT reporter
plasmid. (Lane 10) Control neomycin-resistant clone, transiently
transfected with the pU3R-CAT reporter plasmid. (Lane 11) Positive
control NIH-3T3 cells cotransfected with the LTR-Tax plasmid and the
pU3R-CAT reporter plasmid.
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Figure 6 Morphology of stable clones. Dark-field morphologic appearance of cultures from NIH-3T3 cells transfected with the pNeo plasmid
alone (A) or with the LTR-Tax plasmid plus the pNeo plasmid (B).

NEO

mination of CAT activity. Transactivation of the collagen promoter was evident in several Tax+ clones as illustrated by one
clone in Fig. 7. However, the level of HTLV-1 LTR activation,
reflecting the production of functional Tax, did not correlate
with transactivation of COLlAl promoter.
Levels of type Iprocollagen andfibronectin mRNA in Tax+
stable clones. To investigate the effect of the Tax gene on
the expression of the endogenous COLlAl gene in the stably
transfected clones, total RNA from three control and eight Tax+
clones was extracted and examined by Northern hybridizations
using a murine al (I) procollagen cDNA as a probe. The level
of a l (I) procollagen mRNA was on an average 4.5-fold higher
in Tax+ than in control clones, with a maximal increase of
11.4-fold in one clone (Fig. 8, A and C). However, approximately one-half of the Tax+ clones examined did not show an
increase in the steady state levels for COLlAl. To determine
whether the transactivation by Tax was confined to COLlAl
or extended to genes encoding other extracellular matrix proteins, we also analyzed the mRNA levels for fibronectin in six
Tax+ stable clones. The results shown in Fig. 8, B and D,
indicate that elevated fibronectin mRNA levels were observed
in several Tax+ clones in comparison to controls (pNeo+
clones). On an average, the fibronectin mRNA levels in Tax+
clones were nearly threefold higher than in the two control
clones, although two of the Tax+ clones displayed greater than
fourfold higher levels. It should be noted that the Tax+ clones
displaying the highest levels of al (I) procollagen mRNA
(clones 1, 3, 5, and 6) also displayed the highest levels of
fibronectin transcripts.
Collagen production in Tax+ stable clones. To examine
whether the effects of Tax expression in the Tax+ stable clones

Figure 7. Transactivation of COLlAl promoter in stable clones. Transactivation of
COLlAl promoter in stable clones of NIH3T3 cells obtained by transfection with the

TAX+

pAC1 71

pNeo plasmid alone (NEO) or of a stable

clone obtained by transfection with the LTRTax plasmid plus the pNeo plasmid (TAX+).

(3 9g)

with pNeo alone maintained a typical fibroblastic morphology
with elongated and spindle-shaped cells (Fig. 6 A). In contrast,
clones obtained after transfection with both the LTR-Tax and
pNeo plasmids and expressing functional Tax, as identified
above, contained many cells with stellate morphology, abundant
cytoplasm, and large cytoplasmic extensions (Fig. 6 B).
To demonstrate conclusively that the functionally active Tax
protein, as determined by HTLV-1 LTR transactivation, was
capable of transactivation of the COLlAl promoter, selected
Tax+ clones were transfected with pAC171 followed by deter-
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Figure 8. Northern analyses of total RNA prepared from stably transfected control and Tax+ cell clones. Total RNA was extracted from Tax+
and Neo+ control clones and 10 pg of total RNA was electrophoresed in each lane. After transfer, the filters were hybridized to (A) murine a (I)
procollagen cDNA or (B) murine fibronectin cDNA. Neo, neomycin-resistant control clones. Tax+, Tax producer clones. (C and D) Densitometric
analyses of the Northern hybridizations shown in A and B respectively.
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_Figure 9. SDS-PAGE of
Fibronectin -

[ 4C ] proline extracel-

lular matrix proteins synthesized in stable clones.
NIH-3T3 cells were
transfected with either
pNeo alone or the pNeo
plus LTR-Tax plasmid
1
2
3
4
and stably transfected
L
'
clones were established
NEO
TAX+
as described in Methods.
Cells from the stably transfected clones were cultured to confluency
and then incubated for 24 h with ['4C]proline. After dialysis, 50-Mil
aliquots of pooled medium and cell extract from each clone were used
for the analysis. The figure represents fluorographs of SDS-PAGE of
the radiolabeled media plus cell-associated proteins. NEO, Neomycinresistant control clone. TAX+, Tax+ clones.

Procollagen
+ Collagen

were also reflected at the protein level, collagen production was
determined in four Tax+ stable clones by biosynthetic labeling
of confluent cultures of Tax+ and control pNeo+ clones with
['4C ] proline and determination of collagenase-sensitive proteins. The results illustrated in Fig. 9 indicate that, compared to
control pNeo+ clones, the Tax+ stable clones produced higher
levels of "4C-labeled proteins including [ '4C] collagen. Electrophoretic analysis of the samples indicated that the four Tax+
stable clones which displayed elevated al (I) procollagen and
fibronectin mRNA levels synthesized higher amounts of type
I procollagen and fibronectin. Furthermore, a more efficient
processing of procollagen precursors to mature collagen was
apparent in the Tax+ clones as indicated by the higher proportion of fully processed al and a2 collagen chains (as determined by comparison with the electrophoretic mobility of pure
type I collagen a chains) relative to the intact procollagen
chains. The average ratio of fully processed collagen chains to
intact procollagen chains was 0.94 in 6 Tax+ clones compared
to 0.55 in 3 control clones. This observation was particularly
noticeable in samples from clone 6 (Fig. 9, lane 4) in which
the ratio of fully processed collagen chains to intact procollagen
chains was 1.57.

Discussion
The human type C retrovirus HTLV-1 has been identified as
the causative agent of adult T cell leukemia and has been implicated in the etiology of a progressive demyelinating syndrome
termed HTLV-1-associated myelopathy or tropical spastic
paraparesis (for review see reference 27). Insights into the
pathophysiology of adult T cell leukemia have emerged with
the molecular analysis of HTLV-1 proviral isolates. Like other
retroviruses, HTLV-1 contains dual LTR as well as the three
structural genes gag, pol, and env. In addition, the HTLV-1
genome contains genes encoding the transregulatory proteins
Tax and Rex that regulate viral gene expression (28). Tax
functions as a potent transcriptional activator of the viral LTR
leading to high levels of expression of all viral genes (15, 29,
30). Furthermore, Tax was shown to stimulate the expression
of several cellular promoters including those of IL-2 and its a
receptor, GM-CSF, and c-fos (31-44). It has been further
documented that Tax exerts its function on the transcription of
these genes indirectly by altering the expression of certain host
transcription factors. Altered activation of some members of
2418
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the cAMP response element binding protein/activating transcription factor family has been reported as the mechanism
responsible for the activation of HTLV-1 (39). TGF-f31 and
tissue inhibitor of metalloproteinase-1 appear to be Tax transactivated through promoter elements corresponding with activating protein 1 binding sites that are likely recognized by the
Fos-Jun heterodimer (43, 44). Tax is thought to activate gene
transcription by inducing activating protein 1 gene expression
(38) and by promoting the dimerization of leucine zipper proteins, including activating protein 1, and thus promoting binding
to DNA (45, 46). Tax has also been shown to increase the
DNA binding activity of other transcription factors including
activating transcription factor/cAMP response-element binding
protein, serum response factor, nuclear factor- KB, activating
transcription factor 1, and SpI (46). On the other hand, the
induction of expression of a member of the nuclear factor- KB
family of proteins by Tax has been implicated in the activation
of IL-2 and IL-2a receptor genes (40, 41).
Our previous observations demonstrating that the HIV-1
transactivator protein was capable of inducing the expression
of genes encoding extracellular matrix proteins in glioblastoma
cells (13) led us to examine the biological effect of expression
of the more potent transactivator protein, HTLV-1 Tax on the
promoter activity of COLlA1 in NIH-3T3 cells. Our results
demonstrated that NIH-3T3 cells expressing functional Tax displayed markedly increased activity of the COLlAI promoter.
Although the effects of Tax on COLlAl were of a lower magnitude than its effects on other Tax-responsive cellular genes
such as IL-2 or IL-2a receptor (31-33), they were of similar
magnitude as those of known activators of collagen gene expression such as TGF-f3 (2, 17). Transfection of deletion constructs
of the COLlAl promoter revealed that the region spanning
nucleotides - 174 to -84 appears to be involved in Tax-induced
transactivation of the collagen promoter. In fact, a gene segment
encompassing nucleotides -187 to -67, which contains this
region of the COLlA1 promoter, proved sufficient to confer
Tax inducibility to an HSV tk promoter as shown in Fig. 4.
The stimulation of collagen gene expression by Tax was
further demonstrated using Tax-producing stable clones. Northern blot hybridization analysis of total RNA demonstrated an
elevation in the a I(I) procollagen mRNA levels in several Tax
producer clones. The effects of expression of the HTLV-1 Tax
gene in NIH-3T3 cells were not confined to transactivation of
the COLlAl promoter and the concomitant elevation of the
al (I) procollagen mRNA levels but appeared to extend to
genes encoding other extracellular matrix proteins such as fibronectin. This was evidenced by increased levels of the corresponding transcripts in Tax+ clones. These effects were reflected at the protein level as shown in biosynthetic studies of
collagen and fibronectin production in Tax+ clones. Of particular interest was the observation that procollagen processing into
mature collagen chains was substantially accelerated in Tax+
clones as demonstrated by the higher ratio of fully processed
collagen a-chains relative to intact procollagen. However, there
was not a complete correlation between the activation of the
HTLV-1 LTR and the collagen or fibronectin promoters. The
variability in response of the endogenous collagen and fibronectin genes to Tax has not been investigated but may be related
to dose effects, transfection efficiency, the site of integration of
the HTLV-1 Tax, and the secondary effects that the insertion
may have on other cellular genes. Furthermore, the differential
response of the various promoters to Tax is not entirely unex-

pected, as the level of expression of these genes would depend
on the strength of their corresponding promoters as well as the
differential responsiveness of each promoter to Tax transactivation.
The intimate mechanisms responsible for the increased promoter activity of COLlAl in cells expressing functionally active Tax remain unclear. It is likely that these effects result
from induction of specific transcription factors or the activation
of preexisting ones, as is the case for other cellular genes activated by Tax (31-47). However, it is possible that these effects
may be mediated by cytokines or growth factors whose production or activity is stimulated by Tax. In this context, it is important to consider the possibility that the effects we observed
may be mediated by a Tax-induced increase in the production
of TGF-/3. Evidence is accumulating to indicate that expression
of retroviral proteins can lead to increased production of this
growth factor in vitro (43, 47, 48) as well as in vivo in animals
transgenic for the Tax gene (14, 49, 50). Furthermore, the
changes in collagen and fibronectin observed in Tax+ NIH3T3 cells are similar to those caused by TGF-,l in mesenchymal
cells (for review see reference 5 1), including an increase in the
processing of procollagen as described previously in normal
human dermal fibroblasts (52).
Studies are currently in progress to determine whether induction of various cytokines and growth factors, including TGF,B, by Tax may play a role on the increased expression of genes
encoding extracellular matrix proteins demonstrated here. The
observations described here lead us to suggest that expression
of certain viral proteins may play a role in the fibrosis that
occurs in diseases such as systemic sclerosis and idiopathic
pulmonary fibrosis in which increased extracellular matrix production and/or increased expression of cytokine genes (including those encoding TGF-,Bl ) have been demonstrated. The possibility that cellular expression of retroviral proteins may result
in tissue fibrosis in vivo has been strengthened by the recent
observation that transgenic mice expressing a noninfectious
HIV-1 gene develop severe mesangial fibrosis (14, 53, 54).
Further studies to test this hypothesis may provide clues regarding the etiology and/or pathogenesis of systemic sclerosis and
idiopathic pulmonary fibrosis.
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